E4orf1 induction in adipose tissue promotes insulin-independent signaling in the adipocyte

Molecular Metabolism

Volumn 4, Issue 10, 2015, Pages 653-664

  Kusminski, Christine M ^a   Gallardo Montejano, Violeta I ^a   Wang, Zhao V ^a   Hegde, Vijay ^b   Bickel, Perry E ^a   Dhurandhar, Nikhil V ^b,d   Scherer, Philipp E ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d TEXAS TECH UNIVERSITY   (United States)

Author keywords

Adenovirus; Adipocyte; Adipose tissue; Diabetes; Insulin signaling; Obesity

Indexed keywords

ADIPONECTIN; E1A PROTEIN; E4ORF1 PROTEIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

EID: 84942198081     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.07.004     Document Type: Article

References (47)

1. Samuel V.T., Petersen K.F., Shulman G.I. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010, 375(9733):2267-2277.
2. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nature Reviews Molecular Cell Biology 2006, 7(2):85-96.
3. Abel E.D., Peroni O., Kim J.K., Kim Y.B., Boss O., Hadro E., et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001, 409(6821):729-733.
4. Lo K.A., Labadorf A., Kennedy N.J., Han M.S., Yap Y.S., Matthews B., et al. Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance. Cell Reports 2013, 5(1):259-270.
5. Adams-Huet B., Devaraj S., Siegel D., Jialal I. Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines. Metabolic Syndrome and Related Disorders 2014, 12(10):503-507.
6. Bae S.S., Cho H., Mu J., Birnbaum M.J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. Journal of Biological Chemistry 2003, 278(49):49530-49536.
7. Bluher M., Michael M.D., Peroni O.D., Ueki K., Carter N., Kahn B.B., et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Developmental Cell 2002, 3(1):25-38.
8. Ussar S., Bezy O., Bluher M., Kahn C.R. Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes 2012, 61(9):2289-2298.
9. Rice K.M., Turnbow M.A., Garner C.W. Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 1993, 190(3):961-967.
10. Zierath J.R., Houseknecht K.L., Gnudi L., Kahn B.B. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 1997, 46(2):215-223.
11. Gao Z., Zuberi A., Quon M.J., Dong Z., Ye J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. Journal of Biological Chemistry 2003, 278(27):24944-24950.
12. Clark S.F., Molero J.C., James D.E. Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance. Journal of Biological Chemistry 2000, 275(6):3819-3826.
13. Tan S.X., Ng Y., Burchfield J.G., Ramm G., Lambright D.G., Stockli J., et al. The Rab GTPase-activating protein TBC1D4/AS160 contains an atypical phosphotyrosine-binding domain that interacts with plasma membrane phospholipids to facilitate GLUT4 trafficking in adipocytes. Molecular and Cellular Biology 2012, 32(24):4946-4959.
14. Teruel T., Hernandez R., Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 2001, 50(11):2563-2571.
15. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001, 7(8):941-946.
16. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001, 7(8):947-953.
17. Semple R.K., Soos M.A., Luan J., Mitchell C.S., Wilson J.C., Gurnell M., et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. Journal of Clinical Endocrinology and Metabolism 2006, 91(8):3219-3223.
18. Semple R.K., Halberg N.H., Burling K., Soos M.A., Schraw T., Luan J., et al. Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 2007, 56(6):1712-1717.
19. Thai M., Graham N.A., Braas D., Nehil M., Komisopoulou E., Kurdistani S.K., et al. Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication. Cell Metabolism 2014, 19(4):694-701.
20. Krishnapuram R., Dhurandhar E.J., Dubuisson O., Hegde V., Dhurandhar N.V. Doxycycline-regulated 3T3-L1 preadipocyte cell line with inducible, stable expression of adenoviral E4orf1 gene: a cell model to study insulin-independent glucose disposal. PLoS One 2013, 8(3):e60651.
21. Krishnapuram R., Kirk-Ballard H., Dhurandhar E.J., Dubuisson O., Messier V., Rabasa-Lhoret R., et al. Insulin receptor-independent upregulation of cellular glucose uptake. International Journal of Obesity (London) 2013, 37(1):146-153.
22. Wang Z.Q., Cefalu W.T., Zhang X.H., Yu Y., Qin J., Son L., et al. Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes 2008, 57(7):1805-1813.
23. Dhurandhar E.J., Dubuisson O., Mashtalir N., Krishnapuram R., Hegde V., Dhurandhar N.V. E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS One 2011, 6(8):e23394.
24. Wang Q.A., Tao C., Gupta R.K., Scherer P.E. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nature Medicine 2013, 19(10):1338-1344.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
26. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 1957, 226(1):497-509.
27. Gupta R.K., Arany Z., Seale P., Mepani R.J., Ye L., Conroe H.M., et al. Transcriptional control of preadipocyte determination by Zfp423. Nature 2010, 464(7288):619-623.
28. Dubuisson O., Dhurandhar E.J., Krishnapuram R., Kirk-Ballard H., Gupta A.K., Hegde V., et al. PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells. Endocrinology 2011, 152(10):3648-3660.
29. Schraw T., Wang Z.V., Halberg N., Hawkins M., Scherer P.E. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 2008, 149(5):2270-2282.
30. Ye R., Scherer P.E. Adiponectin, driver or passenger on the road to insulin sensitivity?. Molecular Metabolism 2013, 2(3):133-141.
31. Shetty S., Kusminski C.M., Scherer P.E. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends in Pharmacological Sciences 2009, 30(5):234-239.
32. Na H.N., Hong Y.M., Ye M.B., Park S., Kim I.B., Nam J.H. Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by increasing mitochondrial activity in the liver. PLoS One 2014, 9(12):e114534.
33. Dubuisson O., Day R.S., Dhurandhar N.V. Accurate identification of neutralizing antibodies to adenovirus Ad36, -a putative contributor of obesity in humans. Journal of Diabetes and its Complications 2015, 29(1):83-87.
34. Almgren M., Atkinson R., He J., Hilding A., Hagman E., Wolk A., et al. Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS One 2012, 7(7):e41652.
35. Na H.N., Nam J.H. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. Journal of Infectious Diseases 2012, 205(6):914-922.
36. Turer A.T., Scherer P.E. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012, 55(9):2319-2326.
37. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. Journal of Clinical Investigation 2011, 121(6):2094-2101.
38. Krishnapuram R., Dhurandhar E.J., Dubuisson O., Kirk-Ballard H., Bajpeyi S., Butte N., et al. Template to improve glycemic control without reducing adiposity or dietary fat. American Journal of Physiology-Endocrinology and Metabolism 2011, 300(5):E779-E789.
39. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129(7):1261-1274.
40. Whiteman E.L., Cho H., Birnbaum M.J. Role of Akt/protein kinase B in metabolism. Trends in Endocrinology & Metabolism 2002, 13(10):444-451.
41. Alessi D.R., Downes C.P. The role of PI 3-kinase in insulin action. Biochimica et Biophysica Acta 1998, 1436(1-2):151-164.
42. Vangipuram S.D., Yu M., Tian J., Stanhope K.L., Pasarica M., Havel P.J., et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. International Journal of Obesity (London) 2007, 31(1):87-96.
43. Boucher J., Kleinridders A., Kahn C.R. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harbor Perspectives in Biology 2014, 6(1).
44. Aguirre V., Uchida T., Yenush L., Davis R., White M.F. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). Journal of Biological Chemistry 2000, 275(12):9047-9054.
45. Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 2006, 55(8):2392-2397.
46. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 2002, 277(2):1531-1537.
47. Shah O.J., Wang Z., Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 2004, 14(18):1650-1656.